KRASG12C Mutations and CNS Metastases in Patients with NSCLC

Drs Socinski and Sabari discuss the emergence of the KRAS12C mutation, specifically in patients with CNS metastases and how this factors into their treatment decision.

Related Videos
Expert on lung cancer
Expert on NSCLC
Expert on NSCLC
Expert on NSCLC
Chandler H. Park, MD, an expert on renal cell carcinoma
Edward B. Garon, MD, MS, an expert on lung cancer
Related Content